JULIA P. GREGORY - 17 Sep 2025 Form 4 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role
Director
Signature
/s/ Daniel Burbach, as Attorney-in-Fact for Julia P. Gregory
Issuer symbol
NRIX
Transactions as of
17 Sep 2025
Transactions value $
$19,995
Form type
4
Filing time
17 Sep 2025, 18:58:07 UTC
Previous filing
19 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GREGORY JULIA P Director C/O NURIX THERAPEUTICS, INC., 1700 OWENS STREET, SUITE 205, SAN FRANCISCO /s/ Daniel Burbach, as Attorney-in-Fact for Julia P. Gregory 17 Sep 2025 0001226675

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRIX Common Stock Options Exercise $19,995 +10,750 $1.86 10,750 17 Sep 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRIX Director Stock Option (right to buy) Options Exercise $0 -10,750 -32.3% $0.000000 22,583 17 Sep 2025 Common Stock 10,750 $1.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vested as to 1/48 of the total shares monthly beginning September 12, 2019, and was vested in full on August 12, 2023.